Loading…
[beta]-synuclein aggregates and induces neurodegeneration in dopaminergic neurons
Objective Whereas the contribution of [alpha]-synuclein to neurodegeneration in Parkinson disease is well accepted, the putative impact of its close homologue, [beta]-synuclein, is enigmatic. [beta]-Synuclein is widely expressed throughout the central nervous system, as is [alpha]-synuclein, but the...
Saved in:
Published in: | Annals of neurology 2013-07, Vol.74 (1), p.109-118 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective Whereas the contribution of [alpha]-synuclein to neurodegeneration in Parkinson disease is well accepted, the putative impact of its close homologue, [beta]-synuclein, is enigmatic. [beta]-Synuclein is widely expressed throughout the central nervous system, as is [alpha]-synuclein, but the physiological functions of both proteins remain unknown. Recent findings have supported the view that [beta]-synuclein can act as an ameliorating regulator of [alpha]-synuclein-induced neurotoxicity, having neuroprotective rather than neurodegenerative capabilities, and being nonaggregating due to the absence of most of the aggregation-promoting NAC domain. However, a mutation of [beta]-synuclein linked to dementia with Lewy bodies rendered the protein neurotoxic in transgenic mice, and fibrillation of [beta]-synuclein has been demonstrated in vitro. Methods Neurotoxicity and aggregation properties of [alpha]-, [beta]-, and [gamma]-synuclein were comparatively elucidated in the rat nigro-striatal projection and in cultured neurons. Results Supporting the hypothesis that [beta]-synuclein can act as a neurodegeneration-inducing factor, we demonstrated that wild-type [beta]-synuclein is neurotoxic for cultured primary neurons. Furthermore, [beta]-synuclein formed proteinase K-resistant aggregates in dopaminergic neurons in vivo, leading to pronounced and progressive neurodegeneration in rats. Expression of [beta]-synuclein caused mitochondrial fragmentation, but this fragmentation did not render mitochondria nonfunctional in terms of ion handling and respiration even at late stages of neurodegeneration. A comparison of the neurodegenerative effects induced by [alpha]-, [beta]-, and [gamma]-synuclein revealed that [beta]-synuclein was eventually as neurotoxic as [alpha]-synuclein for nigral dopaminergic neurons, whereas [gamma]-synuclein proved to be nontoxic and had very low aggregation propensity. Interpretation Our results suggest that the role of [beta]-synuclein as a putative modulator of neuropathology in aggregopathies like Parkinson disease and dementia with Lewy bodies needs to be revisited. Ann Neurol 2013;74:109-118 [PUBLICATION ABSTRACT] |
---|---|
ISSN: | 0364-5134 1531-8249 |
DOI: | 10.1002/ana.23905 |